Geno J. Germano - 16 Dec 2025 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Director
Signature: /s/ Dario Scimeca, Attorney-in-fact for Geno Germano
Issuer symbol: DTIL
Transactions as of: 16 Dec 2025
Net transactions value: +$14,160
Form type: 4
Filing time: 17 Dec 2025, 07:02:05 UTC
Previous filing: 31 Jul 2025
Next filing: 09 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Germano Geno J	Director	C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW ST., SUITE A-100, DURHAM	/s/ Dario Scimeca, Attorney-in-fact for Geno Germano	17 Dec 2025	0001424383

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Purchase	$14,160	+3,000	+14%	$4.72	23,883	16 Dec 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.718 to $4.720. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.718 to $4.720. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.